Cohort Profile: Our Future Health

electronic health records; surveys and questionnaires; population health Why was the cohort set up?Our Future Health is a new UK-wide prospective cohort supported by the UK Government, industry, and charity sectors (Figure 1).Our objective is to recruit 5 million adult residents of the UK to facilitate aetiologic and translational research.This research will enable everyone to live longer, healthier lives by accelerating the discovery and testing of better ways to prevent, detect, and treat diseases.Our Future Health also aims to recruit a diverse cohort that reflects the UK population.Ethically, it is important that Key Features Our Future Health is the UK's largest health research programme with an ambition to recruit 5 million UK-resident adult participants into a prospective cohort study. Our mission is to help everyone live longer, healthier lives through the discovery and testing of more effective approaches to the prevention, earlier detection, and treatment of diseases. Recruitment opened in October 2022.By June 2025, 2.4 million participants had consented, 1.8 million had completed the baseline questionnaire, 1.3 million had been linked to electronic health records, and 1.4 million had completed an in-person appointment to donate health metrics and blood. Genotyping is conducted using a 700 000-variant custom array that is optimized for multi-ethnic imputation and has up-to-date disease-, phenotype-, blood type-, and pharmacogenomic-associated variants. The cohort includes >600 000 people aged 18-40 years, facilitating research into diseases that disproportionately affect younger people, including obesity, mental health disorders, and addiction, and 900 000 people aged >60 years, enabling research into vascular dementia, Alzheimer's, and ageing. Our Future Health will catalyse translational research by facilitating access to stored biosamples and by enabling re-contact studies and trials with participants selectively invited based on demographics, phenotypes, and disease risks.

Authors

Institutions

Publication Details

Journal
International Journal of Epidemiology
Published
2025-10-14
DOI
https://doi.org/10.1093/ije/dyaf171
Citations
1
Primary Topic
Birth, Development, and Health
Type
article
Field-Weighted Citation Impact
3.49
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cohort Profile: Our Future Health

Iain Turnbull, Andrea Forman, Michael B. Cook, Saskia C. Sanderson et al.
1 citations
International Journal of Epidemiology
Birth, Development, and Health
3.49
article

Cohort Profile: Our Future Health

Iain Turnbull, Andrea Forman, Michael B. Cook, Saskia C. Sanderson, Raghib Ali, Alicia J. Peel, Fiona Reddington, Rachel Moran, Ros Blackwood, A M Connell, Ryan Arathimos, Kirstin L. Purves, Diana van der Plaat, Jodie Lord, Naomi Adams, Adam Steventon, Andrew Roddam, Scott North, Fiona Grimm, Tim Sprosen, Adam Booth, Emma Vestesson, F. Maleady-Crowe, Simon J. Ellis, Benjamin Elsworth, Benjamin J. Cairns, Kate Evans, David J. Hunter, Eva Gradovich, Cosima Gretton, Kamil Lipinski, Jane Luff, Ashley Adjetey, Marko Balabanovic
article en
1 citations

Abstract

electronic health records; surveys and questionnaires; population health Why was the cohort set up?Our Future Health is a new UK-wide prospective cohort supported by the UK Government, industry, and charity sectors (Figure 1).Our objective is to recruit 5 million adult residents of the UK to facilitate aetiologic and translational research.This research will enable everyone to live longer, healthier lives by accelerating the discovery and testing of better ways to prevent, detect, and treat diseases.Our Future Health also aims to recruit a diverse cohort that reflects the UK population.Ethically, it is important that Key Features Our Future Health is the UK's largest health research programme with an ambition to recruit 5 million UK-resident adult participants into a prospective cohort study. Our mission is to help everyone live longer, healthier lives through the discovery and testing of more effective approaches to the prevention, earlier detection, and treatment of diseases. Recruitment opened in October 2022.By June 2025, 2.4 million participants had consented, 1.8 million had completed the baseline questionnaire, 1.3 million had been linked to electronic health records, and 1.4 million had completed an in-person appointment to donate health metrics and blood. Genotyping is conducted using a 700 000-variant custom array that is optimized for multi-ethnic imputation and has up-to-date disease-, phenotype-, blood type-, and pharmacogenomic-associated variants. The cohort includes >600 000 people aged 18-40 years, facilitating research into diseases that disproportionately affect younger people, including obesity, mental health disorders, and addiction, and 900 000 people aged >60 years, enabling research into vascular dementia, Alzheimer's, and ageing. Our Future Health will catalyse translational research by facilitating access to stored biosamples and by enabling re-contact studies and trials with participants selectively invited based on demographics, phenotypes, and disease risks.

International Journal of EpidemiologyVol. 54(6)
Harvard University (US), King's College London (GB), University of Cambridge (GB), Manchester Academic Health Science Centre (GB), Mental Health Research UK (GB), University of Oxford (GB), Future Science Group (United Kingdom) (GB), Project Everyone (GB), MRC Epidemiology Unit (GB), University College London (GB), Imperial College London (GB)
Openalex Percentile: Top 7%
Birth, Development, and Health
3.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.